Company Filing History:
2 out of 2 
1 out of 3 
1 out of 832,812 Years Active: 2000-2021
Title: Franco Venanzi: Innovator in Inflammation and Cancer Treatment
Introduction
Franco Venanzi is a notable inventor based in Camerino, Italy. He has made significant contributions to the fields of inflammation and cancer treatment through his innovative research and patented technologies. With a total of 4 patents, Venanzi's work focuses on the modulation of inflammatory diseases and cancer prevention.
Latest Patents
Franco Venanzi's latest patents include methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases. These novel p62 compositions are designed to modulate the expression of proinflammatory cytokines, osteogenic transcription factors, and bone resorptive factors. The applications of these compositions are extensive, targeting various inflammatory diseases such as osteoporosis, obesity, type 2 diabetes, and neurodegenerative diseases. Additionally, he has developed methods and compositions relating to p62 for the treatment and prophylaxis of cancer, which enhance the anti-cancer activity of p62.
Career Highlights
Throughout his career, Franco Venanzi has worked with prominent organizations, including Curelab Oncology, Inc. and Università Degli Studi Di Camerino. His research has been pivotal in advancing the understanding and treatment of complex diseases, particularly those related to inflammation and cancer.
Collaborations
Franco Venanzi has collaborated with notable professionals in his field, including Alexander Shneider and Michael Sherman. These partnerships have contributed to the development of innovative solutions in medical research.
Conclusion
Franco Venanzi's contributions to the fields of inflammation and cancer treatment through his patents and collaborations highlight his role as a leading inventor. His work continues to impact the medical community and offers hope for the treatment of various diseases.